Literature DB >> 6259735

Epstein-Barr viral DNA: infectivity for human placental cells.

G Miller, E Grogan, L Heston, J Robinson, D Smith.   

Abstract

Purified DNA of Epstein-Barr virus (EBV) is regularly infectious by means of the "calcium" method of transfection. Cultured human placental cells exposed to EBV DNA of two transforming strains, FF41 and B95, produce virus that is capable of converting normal B lymphocytes into established cell lines. After treatment with EBV (FF41) DNA and EBV (HR-1) DNA the placental cells display antigens associated with the productive viral cycle. The placental cells have not developed foci or other signs of morphologic transformation.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6259735     DOI： 10.1126/science.6259735

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


  13 in total

1.  Characterization of the restricted component of Epstein-Barr virus early antigens as a cytoplasmic filamentous protein.

Authors:  J Luka; G Miller; H Jörnvall; G R Pearson
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

2.  Epstein-Barr virus infection of epithelial cells derived from primary cultures of adenoidal tissue.

Authors:  M Furukawa; H Sakashita; C Kato; R Umeda
Journal:  Eur Arch Otorhinolaryngol       Date:  1990       Impact factor: 2.503

3.  Synergistic activation of cells by Epstein-Barr virus and B-cell growth factor.

Authors:  L M Hutt-Fletcher
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

Review 4.  Does neoplasia in-situ develop due to the interaction of Epstein-Barr virus or herpes simplex virus-2 with Langerhans cells in the epithelium?

Authors:  Y Becker
Journal:  Virus Genes       Date:  1988-07       Impact factor: 2.332

5.  Expression of Epstein-Barr viral early antigen in monolayer tissue cultures after transfection with viral DNA and DNA fragments.

Authors:  E Grogan; G Miller; W Henle; M Rabson; D Shedd; J C Niederman
Journal:  J Virol       Date:  1981-12       Impact factor: 5.103

6.  Expression in COS-1 cells of Epstein-Barr virus nuclear antigen from a complete gene and a deleted gene.

Authors:  M F Robert; D Shedd; R J Weigel; D K Fischer; G Miller
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

7.  Identification of Epstein-Barr nuclear antigen polypeptide in mouse and monkey cells after gene transfer with a cloned 2.9-kilobase-pair subfragment of the genome.

Authors:  D K Fischer; M F Robert; D Shedd; W P Summers; J E Robinson; J Wolak; J E Stefano; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

8.  Expression of a nuclear and a cytoplasmic Epstein-Barr virus early antigen after DNA transfer: cooperation of two distant parts of the genome for expression of the cytoplasmic antigen.

Authors:  K Takaki; A Polack; G W Bornkamm
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

9.  Stable expression in mouse cells of nuclear neoantigen after transfer of a 3.4-megadalton cloned fragment of Epstein-Barr virus DNA.

Authors:  W P Summers; E A Grogan; D Shedd; M Robert; C R Liu; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

10.  Non-immortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent, Jijoye.

Authors:  M Rabson; L Gradoville; L Heston; G Miller
Journal:  J Virol       Date:  1982-12       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.